Clinical trial · Observational
Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy
A PROGNOSTIC SCORE TO PREDICT MAJOR COMPLICATIONS AFTER PANCREATICODUODENECTOMY.
NCT01278381CI-TRIAL-00004293completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pancreaticoduodenectomy (PD) still carries a high rate of severe postoperative complications. No score is currently available to help identify the patient's surgical risk. The purpose of this study was to develop and validate a prognostic score to predict major postoperative complications after PD.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasm | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pancreaticoduodenectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Pancreaticoduodenectomy (PD)
- description
- Patients undergoing PD from 2002 to 2010
- interventionNames
- Procedure: Pancreaticoduodenectomy
Primary outcomes (1)
- measure
- Major Complication rate
- timeFrame
- Postoperative. Until 30 days after discharge
- description
- Clavien-Dindo grade III to V complications considered as major
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: \- Patients undergoing pancreaticoduodenectomy in our Institution Exclusion Criteria: * Metastatic disease * Patient not suitable for surgery
References
Publications (0)
Data not yet available
No reference posted for this study.